Literature DB >> 22092567

Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.

Takashi Hirano1, Satoru Kodama, Toshiaki Kawano, Kazuhiko Maeda, Masashi Suzuki.   

Abstract

Acute otitis media (AOM) is one of the most common infectious diseases in children. Nontypeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis, Gram-negative bacteria, are considered major pathogens of AOM and respiratory tract infections. In this study, we used monophosphoryl lipid A (MPL) as a Toll-like receptor (TLR4) agonist to induce innate immune responses before challenge with NTHi and M. catarrhalis to enhance bacterial clearance from the nasopharynx. Mice were intranasally administered 40, 10, or 1 μg of MPL and challenged with NTHi and M. catarrhalis 12 and 24 h later. At 6 and 12 h after the bacterial challenge, the mice were killed and nasal washes were collected. The numbers of NTHi, M. catarrhalis, and inflammatory cells were quantitated. Inoculation of MPL produced a significant reduction in the number of bacteria recovered from the nasopharynx at 6 and/or 12 h after the bacterial challenge, when compared with control mice. The effect was dose dependent. MPL inoculation also induced the early accumulation of neutrophils in the nasopharynx after exposure to bacteria. MPL is effective for eliciting clearance of both NTHi and M. catarrhalis from the nasopharynx. These results indicate the possibility of a new strategy against Gram-negative bacterial infection that involves the stimulation of the innate immune system by TLR4 agonists such as MPL.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092567     DOI: 10.1111/j.1574-695X.2011.00866.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  8 in total

1.  Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.

Authors:  Haiyue Xu; Tinashe B Ruwona; Sachin G Thakkar; Yanping Chen; Mingtao Zeng; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

Review 2.  The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.

Authors:  Julia K Bohannon; Antonio Hernandez; Perenlei Enkhbaatar; William L Adams; Edward R Sherwood
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

3.  Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.

Authors:  Akitaka Tanaka; Shigeki Nakamura; Masafumi Seki; Kenji Fukudome; Naoki Iwanaga; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Katsunori Yanagihara; Shigeru Kohno
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

Review 4.  Immunotherapy for tularemia.

Authors:  Jerod A Skyberg
Journal:  Virulence       Date:  2013-06-19       Impact factor: 5.882

Review 5.  Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications.

Authors:  Chung-Nga Ko; Shaohong Zang; Yingtang Zhou; Zhangfeng Zhong; Chao Yang
Journal:  J Nanobiotechnology       Date:  2022-08-19       Impact factor: 9.429

6.  Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice.

Authors:  Tao Hua; Chen Chang; Xuehua Zhang; Yuqing Huang; Haiyan Wang; Daohua Zhang; Bo Tang
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

Review 7.  Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.

Authors:  Chih-Yuan Chiang; Ijeoma Uzoma; Richard T Moore; Merle Gilbert; Allen J Duplantier; Rekha G Panchal
Journal:  mBio       Date:  2018-01-30       Impact factor: 7.867

Review 8.  The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma.

Authors:  Margaret A McBride; Allison M Owen; Cody L Stothers; Antonio Hernandez; Liming Luan; Katherine R Burelbach; Tazeen K Patil; Julia K Bohannon; Edward R Sherwood; Naeem K Patil
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.